Dashboard
Manage Tickers

RGEN REPLIGEN CORP

Nasdaq repligen.com


$ 152.40 $ -1.95 (-1.26 %)    

Friday, 17-Oct-2025 18:34:14 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 152.6
$ 153.50
$ 145.01 x 250
$ 159.59 x 100
$ 152.54 - $ 156.31
$ 102.97 - $ 182.52
1,068,960
na
8.58B
$ 1.53
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 04-29-2025 03-31-2025 10-Q
3 03-13-2025 12-31-2024 10-K
4 11-18-2024 09-30-2024 10-Q
5 07-30-2024 06-30-2024 10-Q
6 05-01-2024 03-31-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 10-31-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-02-2023 03-31-2023 10-Q
11 02-22-2023 12-31-2022 10-K
12 11-01-2022 09-30-2022 10-Q
13 08-02-2022 06-30-2022 10-Q
14 04-27-2022 03-31-2022 10-Q
15 02-17-2022 12-31-2021 10-K
16 10-28-2021 09-30-2021 10-Q
17 07-27-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-24-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 07-30-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 02-26-2020 12-31-2019 10-K
24 10-31-2019 09-30-2019 10-Q
25 08-01-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 03-01-2019 12-31-2018 10-K
28 11-01-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-08-2018 03-31-2018 10-Q
31 02-22-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-03-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 02-23-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-05-2016 03-31-2016 10-Q
39 02-25-2016 12-31-2015 10-K
40 11-05-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

evercore-isi-group-maintains-outperform-on-repligen-raises-price-target-to-175
Evercore ISI Group Maintains Outperform on...
10/07/2025 17:51:20

Evercore ISI Group analyst Daniel Markowitz maintains Repligen (NASDAQ:RGEN) with a Outperform and raises the price target f...

barclays-maintains-overweight-on-repligen-raises-price-target-to-160
Barclays Maintains Overweight on Repligen,...
10/02/2025 13:30:44

Barclays analyst Luke Sergott maintains Repligen (NASDAQ:RGEN) with a Overweight and raises the price target from $150 to $160.

what-8-analyst-ratings-have-to-say-about-repligen
What 8 Analyst Ratings Have To Say About R...
10/01/2025 20:01:23

hsbc-initiates-coverage-on-repligen-with-buy-rating-announces-price-target-of-150
HSBC Initiates Coverage On Repligen with B...
10/01/2025 17:22:44

HSBC analyst Yessica Sanchez initiates coverage on Repligen (NASDAQ:RGEN) with a Buy rating and announces Price Target of $150.

this-sarepta-therapeutics-analyst-turns-bullish-here-are-top-5-upgrades-for-monday
This Sarepta Therapeutics Analyst Turns Bu...
09/22/2025 12:43:32

evercore-isi-group-upgrades-repligen-to-outperform-raises-price-target-to-155
Evercore ISI Group Upgrades Repligen to Ou...
09/22/2025 11:33:53

Evercore ISI Group analyst Daniel Markowitz upgrades Repligen (NASDAQ:RGEN) from In-Line to Outperform and raises the price ...

jefferies-maintains-hold-on-repligen-lowers-price-target-to-135
Jefferies Maintains Hold on Repligen, Lowe...
09/12/2025 10:20:19

Jefferies analyst Matthew Stanton maintains Repligen (NASDAQ:RGEN) with a Hold and lowers the price target from $145 to $135.

analyst-expectations-for-repligens-future
Analyst Expectations For Repligen's Future
09/03/2025 12:00:50

hc-wainwright--co-reiterates-buy-on-repligen-maintains-180-price-target
HC Wainwright & Co. Reiterates Buy on Repl...
09/03/2025 10:49:16

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Repligen (NASDAQ:RGEN) with a Buy and maintains $180 price tar...

repligen-stock-outlook-risk-skewed-to-the-downside-through-2026
Repligen Stock Outlook: Risk Skewed To The...
07/31/2025 14:45:50

Repligen stock has been in a prolonged downtrend, and Adhishthana principles suggest more weakness ahead. Here's what inves...

repligen-partners-with-novasign-to-advance-digital-twins-and-predictive-process-control-for-bioprocessing-workflows
Repligen Partners With Novasign To Advance...
07/31/2025 11:38:04

rbc-capital-maintains-outperform-on-repligen-raises-price-target-to-204
RBC Capital Maintains Outperform on Replig...
07/30/2025 14:40:27

RBC Capital analyst Conor McNamara maintains Repligen (NASDAQ:RGEN) with a Outperform and raises the price target from $193 ...

wells-fargo-maintains-overweight-on-repligen-lowers-price-target-to-175
Wells Fargo Maintains Overweight on Replig...
07/30/2025 14:11:17

Wells Fargo analyst Brandon Couillard maintains Repligen (NASDAQ:RGEN) with a Overweight and lowers the price target from $1...

repligen-raises-fy2025-adj-eps-guidance-from-163-172-to-165-172-vs-168-est-raises-fy2025-sales-guidance-from-695000m-720000m-to-715000m-735000m-vs-709438m-est
Repligen Raises FY2025 Adj EPS Guidance fr...
07/29/2025 11:33:59

Repligen (NASDAQ:RGEN) raises FY2025 Adj EPS guidance from $1.63-$1.72 to $1.65-$1.72 vs $1.68 analyst estimate. Raises FY2025 ...

repligen-q2-adj-eps-037-misses-039-estimate-sales-182000m-beat-174831m-estimate
Repligen Q2 Adj. EPS $0.37 Misses $0.39 Es...
07/29/2025 11:33:02

Repligen (NASDAQ:RGEN) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0.39 by 5...

Core News & Articles
Earnings Scheduled For July 29, 2025
07/29/2025 08:32:31

forecasting-the-future-6-analyst-projections-for-repligen
Forecasting The Future: 6 Analyst Projecti...
07/22/2025 19:00:59

stephens--co-assumes-repligen-at-overweight-announces-price-target-of-160
Stephens & Co. Assumes Repligen at Overwei...
07/22/2025 15:07:14

Stephens & Co. analyst Steven Etoch assumes Repligen (NASDAQ:RGEN) with a Overweight rating and announces Price Target o...

evercore-isi-group-maintains-in-line-on-repligen-lowers-price-target-to-130
Evercore ISI Group Maintains In-Line on Re...
07/08/2025 13:04:36

Evercore ISI Group analyst Daniel Markowitz maintains Repligen (NASDAQ:RGEN) with a In-Line and lowers the price target from...

what-analysts-are-saying-about-repligen-stock
What Analysts Are Saying About Repligen Stock
06/24/2025 20:00:32

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION